Glp for Weight Loss - Search News

HealthDay on MSN · 5d

Medicaid covers GLP-1 weight-loss drugs in just 13 states

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Dallas Morning News on MSN · 3d

FDA adds new warning to weight loss drugs including Wegovy

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.

Barron's on MSN · 4d

Novo Nordisk Posts Mixed Results, Adding to Jitters About Weight-Loss Drugs

A mixed sales report for Novo Nordisk’s GLP-1 megablockbuster drugs failed to quiet concerns Wednesday that investors may have overestimated the market for its new weight-loss and diabetes medicines.

Reuters on MSN · 4d

Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow compounding pharmacies to copy brand-name medicines that are in short supply by combining,

9d

Compounded GLP-1s for Weight Loss: What Are They and Are They Safe?

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Weight-loss pill passes important safety test in clinical trial

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

GLP-1 Use Presurgery Safe but No Weight Loss Boost

Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with ...

Crain's Chicago Business9d

Endevica bets it has a weight-loss drug to beat GLP-1s with spinoff

A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...

Outsourcing-pharma10d

Competitors race to launch GLP-1 drugs amid soaring weight loss demand

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results